article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 5 As with other organ transplants, the organs are at risk of rejection. Pediatr Transplant.

article thumbnail

Transplant Advocates Sound Alarm Over Proposed Medicare Test Coverage Policy

Med Page Today

(MedPage Today) -- WASHINGTON -- Heart transplant patient Eddie Garcia was "feeling like a million bucks" one day in the summer of 2021. He had just gotten back from a 3-mile walk, something he couldn't do prior to his transplant in 2020 -.

article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. All rights reserved. 4 Fine, N.

article thumbnail

Impact of Heart Transplant Allocation Changes on Waitlist Mortality and Clinical Practice in Pediatric and Adult Patients With Congenital Heart Disease and Cardiomyopathy

Circulation

Cohorts were grouped into preallocation and postallocation change eras: pediatric patients from January 1, 2011, to March 21, 2016, and January 1, 2017, to December 31, 2021; and adult patients from January 1, 2015, to October 17, 2018, and January 1, 2019, to December 31, 2021.

article thumbnail

FDA Announces Abbott Recall of HeartMate 3 Left Ventricular Assist System (LVAS) Implant Kit

DAIC

882 Dates Distributed: March 1, 2021 to present Date Initiated by Firm: March 13, 2024 Device Use The HeartMate 3 Left Ventricular Assist System (LVAS) is used to help the heart pump blood when it is not able to do so effectively on its own.

article thumbnail

What is new in Heart failure management ? Ultrasonic cardiac re-synchronization : The WiSE -CRT device

Dr. S. Venkatesan MD

2021 May 21;23(5):740-747. However, advanced heart failure therapy never means it can be achieved only by state-of-the-art technology. Only few lucky patients end up getting heart transplantation, the ultimate treatment. Heart Rhythm. Epub 2021 Jul 29. CRT, cardiac resynchronization therapy. 2021.06.1195.

article thumbnail

Phenotypes in Arrhythmogenic Cardiomyopathy

All About Cardiovascular System and Disorders

Heart failure, heart transplantation and death by cardiac causes were more often seen in individuals with biventricular phenotype compared to isolated left or right ventricular phenotype. 2021 Jun 7;23(6):907-917. ‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy.